/

Other

/

Tris Pharma

Tris Pharma

Tris Pharma

Verified Nov 2026

Other

·

United States flag

·

Since 2000

Tris Pharma is a privately held biopharmaceutical manufacturer headquartered in Monmouth Junction, New Jersey, founded in 2000. With 500–1,000 employees and estimated revenue of $50–100 million, the company develops and commercializes medicines for central nervous system disorders including ADHD, pain, and addiction. It employs proprietary sustained-release technology called LiquiXR to create prescription and over-the-counter formulations, and recently expanded into digital health diagnostics for neurological conditions.

Tris Pharma

Verified Nov 2026

AT A GLANCE

Founded

2000

Headquarters

United States flag

Employees

500-1,000

Ownership

Tris Pharma at a glance

Revenue

$50-100M

Est. band

Employees

500-1,000

Founded

2000

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Tris Pharma is a privately held biopharmaceutical manufacturer headquartered in Monmouth Junction, New Jersey, founded in 2000. With 500–1,000 employees and estimated revenue of $50–100 million, the company develops and commercializes medicines for central nervous system disorders including ADHD, pain, and addiction. It employs proprietary sustained-release technology called LiquiXR to create prescription and over-the-counter formulations, and recently expanded into digital health diagnostics for neurological conditions.

At a glance

Attribute

Detail

Founded

2000

Employees

500-1,000

Revenue

$50-100M (estimated)

What Tris Pharma makes

The company holds over 150 patents and uses its proprietary LiquiXR sustained-release technology platform to develop diverse dosage forms for extended-period medication delivery.

Latest developments

Company details

Tris Pharma serves patients, healthcare providers, and pharmacies as a specialty pharmaceutical player with a pipeline of candidates and received FDA orphan drug designation in June 2026. Tris Pharma was founded in 2000, and has an estimated 500-1,000 employees.

Frequently asked questions

What does Tris Pharma do?

Tris Pharma is a privately held biopharmaceutical manufacturer headquartered in Monmouth Junction, New Jersey, founded in 2000. With 500–1,000 employees and estimated revenue of $50–100 million, the company develops and commercializes medicines for central nervous system disorders including ADHD, pain, and addiction. It employs proprietary sustained-release technology called LiquiXR to create prescription and over-the-counter formulations, and recently expanded into digital health diagnostics for neurological conditions.

When was Tris Pharma founded?

Tris Pharma was founded in 2000.

How big is Tris Pharma?

Tris Pharma has an estimated 500-1,000 employees, with revenue in the $50-100M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

New JerseyHeadquarters · United States
New Jersey2031 US-130, New Jersey, 08852, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.